Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: March 2018
Remove filter for
Last updated: 2018
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 4 of 4 items.
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
AlertHealth professional risk communication | 2018-03-16
0.9% Sodium Chloride Injection, 250 mL (2018-03-16)
RecallHealth product recall | 2018-03-16
Health Canada to conduct review of a new potential safety risk of Fibristal (ulipristal acetate), a medication used to treat fibroids
AlertInformation update | 2018-03-15
Phenylbutazone powder (2018-03-02)
RecallHealth product recall | 2018-03-02